Guardion Health Sciences Inc
NASDAQ:GHSI
Intrinsic Value
Guardion Health Sciences, Inc.is a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provid... [ Read More ]
The intrinsic value of one GHSI stock under the Base Case scenario is 6.07 USD. Compared to the current market price of 8.92 USD, Guardion Health Sciences Inc is Overvalued by 32%.
Valuation Backtest
Guardion Health Sciences Inc
Run backtest to discover the historical profit from buying and selling GHSI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Guardion Health Sciences Inc
Current Assets | 12.8m |
Cash & Short-Term Investments | 7.7m |
Receivables | 1.8m |
Other Current Assets | 3.4m |
Non-Current Assets | 40k |
PP&E | 40k |
Current Liabilities | 1.4m |
Accounts Payable | 880k |
Accrued Liabilities | 550k |
Non-Current Liabilities | 3.8m |
Other Non-Current Liabilities | 3.8m |
Earnings Waterfall
Guardion Health Sciences Inc
Revenue
|
12.1m
USD
|
Cost of Revenue
|
-7.1m
USD
|
Gross Profit
|
5m
USD
|
Operating Expenses
|
-9.5m
USD
|
Operating Income
|
-4.5m
USD
|
Other Expenses
|
-5.6m
USD
|
Net Income
|
-10.1m
USD
|
Free Cash Flow Analysis
Guardion Health Sciences Inc
What is Free Cash Flow?
GHSI Profitability Score
Profitability Due Diligence
Guardion Health Sciences Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Guardion Health Sciences Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
GHSI Solvency Score
Solvency Due Diligence
Guardion Health Sciences Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Score
Guardion Health Sciences Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GHSI Price Targets Summary
Guardion Health Sciences Inc
According to Wall Street analysts, the average 1-year price target for GHSI is 40.8 USD with a low forecast of 40.4 USD and a high forecast of 42 USD.
Ownership
GHSI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
GHSI Price
Guardion Health Sciences Inc
Average Annual Return | -36.53% |
Standard Deviation of Annual Returns | 93.59% |
Max Drawdown | -100% |
Market Capitalization | 11.4m USD |
Shares Outstanding | 1 275 240 |
Percentage of Shares Shorted | 12.63% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Guardion Health Sciences, Inc.is a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provide supportive health benefits to consumers. The company is headquartered in Houston, Texas and currently employs 13 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products and devices designed to support healthcare professionals and providers, and their patients and consumers. The Company, through Activ Nutritional, LLC (Activ), owns the Viactiv line of supplement chews for bone health, immune health, and other applications. The Viactiv line of supplements contains several flavored nutritional supplement products, but the milk chocolate and caramel-flavored calcium chews constitute the main product category. The company also sells Lumega-Z, its medical food product that has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. The firm's GlaucoCetin, a medical food, which offers a formula that is designed to support proper mitochondrial function in the optic nerve cells in glaucoma patients.
Contact
IPO
Employees
Officers
The intrinsic value of one GHSI stock under the Base Case scenario is 6.07 USD.
Compared to the current market price of 8.92 USD, Guardion Health Sciences Inc is Overvalued by 32%.